z-logo
Premium
Some characteristics and purification of anti‐(human ovarian carcinoma)×anti‐(human CD3) single‐chain bispecific antibody
Author(s) -
Zhou Feng,
Wei DongZhi,
Tong WangYu,
Zhu YiQi,
Jiang YunMei
Publication year - 2007
Publication title -
biotechnology and applied biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 70
eISSN - 1470-8744
pISSN - 0885-4513
DOI - 10.1042/ba20060149
Subject(s) - molecular mass , solubility , isoelectric point , chemistry , isoelectric focusing , chromatography , pi , yield (engineering) , enzyme , biochemistry , organic chemistry , materials science , metallurgy
To obtain high‐quality AhOC×AhCD3 [anti‐(human ovarian carcinoma)×anti‐(human CD3)] with high biological activity economically and easily, some characteristics and purification of AhOC×AhCD3, a single chain bispecific antibody, were investigated. During the present study, some important properties of AhOC×AhCD3, such as molecular mass, pI, solubility, stability, hydrophobic ability, molecular status and bioactivity were primarily studied. The molecular mass of AhOC×AhCD3 was determined to be approx. 58.0 kDa by SDS/PAGE (theoretical molecular mass: 56972.5 Da, calculated on the basis of the primary structure) and the pI was approx. 7.5±0.4 by IEF (isoelectric focusing; theoretical pI: 8.5, predicted by the ProtParam software tool) respectively. Experiments showed that the solubility of AhOC×AhCD3 increased with the pH increase and that the AhOC×AhCD3 was easily degraded into several fragments during the storage time of samples and the mixtures of both fragment B and fragment C retained normal bioactivity. Particularly, the soluble aggregate/polymer status of AhOC×AhCD3 with bioactivity was verified by non‐reducing SDS/PAGE. After optimization of purification process, AhOC×AhCD3 with electrophoretic homogeneity was successfully obtained and the yield was approx. 20%. Some important properties of AhOC×AhCD3 were first observed and a procedure for soluble AhOC×AhCD3 purification in scale‐up was first established. Some characteristics of AhOC×AhCD3, especially the stability of AhOC×AhCD3, are critical for the development of this protein pharmaceutical and useful for reference to other proteins.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here